Formulate Financial’s iShares S&P 500 Growth ETF IVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.48M Buy
54,414
+1,616
+3% +$213K 7.88% 6
2026
Q1
$5.97M Buy
52,798
+1,665
+3% +$200K 7.37% 6
2025
Q4
$6.3M Buy
51,133
+3,696
+8% +$452K 7.39% 6
2025
Q3
$5.73M Buy
+47,437
New +$5.46M 7.1% 6

Other funds holding IVW

Formulate Financial's IVW Position: Q2 2026 in Review

Formulate Financial increased its iShares S&P 500 Growth ETF (IVW) stake by 3.1% in Q2 2026, buying an estimated $213K and bringing the position to 54,414 shares worth $7.48M. The position accounts for 7.88% of the portfolio, ranked #6.

Formulate Financial first reported a position in IVW in Q3 2025 and has held it in 4 quarters since. 1,498 funds tracked by Wall St. Rank hold IVW as of Q2 2026.

  • Formulate Financial held 54,414 shares of iShares S&P 500 Growth ETF worth $7.48M as of Q2 2026.
  • Formulate Financial bought 1,616 iShares S&P 500 Growth ETF shares in Q2 2026, an estimated $213K.
  • iShares S&P 500 Growth ETF made up 7.88% of Formulate Financial's portfolio in Q2 2026, its #6 holding.
  • Formulate Financial first reported a position in iShares S&P 500 Growth ETF in Q3 2025 and has held it in 4 quarters since.
  • 1,498 funds tracked by Wall St. Rank held iShares S&P 500 Growth ETF as of Q2 2026.

Based on Formulate Financial's 13F filing for Q2 2026, filed 31 Jul 2026.